Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function

NCT02471963 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

University of Erlangen-Nürnberg Medical School